Clinical Trial Details

Overview

Research Study Summary

Bipolar Depression study with 6-month open-label therapy

Purpose

If you or someone you know suffers from bipolar depression, you may be eligible to participate in a research medication study. This study consists of 8 weeks followed by 6 months of open-label therapy. Qualified participants are eligible to receive the following at no cost: study medication, medical and psychiatric assessments, lab work and sessions with a physician and/or a clinical study coordinator.

Patient Inclusion/Exclusion Criteria:

  • Males and females 18 years and older.
  • Subjects must be diagnosed with bipolar depression
  • Must have experienced at least one previous manic or mixed episode
  • Subjects must not have any serious, unstable illnesses or have substance dependence within the past 30 days.
To Learn more

CW ID: 25374
Date Last Changed: July 25, 2013

Clinical Trial Snapshot

Gender
Both Male and Female
Age
18 and up
Overall Status
Recruiting
Facility Type
N/A

Contact

Carol Shreve
Bayou City Research Corporation
550 Westcott
Suite 310
Houston, TX 77007
Phone: 832-251-7000
Fax: 832-251-7011

View Map

Research Center Information: Bayou City Research Corporation

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.